NasdaqGM - Nasdaq Real Time Price USD

Liminatus Pharma, Inc. (LIMN)

7.45
+1.29
+(20.94%)
At close: 4:00:00 PM EDT
7.35
-0.10
(-1.34%)
After hours: 7:40:31 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
Total Revenue
0
0
0
Operating Expense
3,925
4,819
2,709
Operating Income
-3,925
-4,819
-2,709
Net Non Operating Interest Income Expense
-163
-165
-219
Pretax Income
-4,088
-4,984
-2,928
Net Income Common Stockholders
-4,088
-4,984
-2,928
Diluted NI Available to Com Stockholders
-4,088
-4,984
-2,928
Basic EPS
-0.15
-0.19
-0.11
Diluted EPS
-0.15
-0.19
-0.11
Basic Average Shares
26,714.63
26,714.63
26,714.63
Diluted Average Shares
26,714.63
26,714.63
26,714.63
Total Operating Income as Reported
-3,925
-4,819
-2,709
Total Expenses
3,925
4,819
2,709
Net Income from Continuing & Discontinued Operation
-4,088
-4,984
-2,928
Normalized Income
-4,088
-4,984
-2,928
Interest Income
87
10
0
Interest Expense
250
175
219
Net Interest Income
-163
-165
-219
EBIT
-3,838
-4,809
-2,709
EBITDA
-3,838
-4,809
-2,709
Net Income from Continuing Operation Net Minority Interest
-4,088
-4,984
-2,928
Normalized EBITDA
-3,838
-4,809
-2,709
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
12/31/2022 - 5/2/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers